Elpida is a Social Purpose Corporation developing gene therapy treatments for children with rare diseases.

Oulyer Group aims to Enable the World differently!

Drake is helping to Build a Better Future!I serve as a member of the Board of Directors for Drake Bank which is focused on helping small businesses in the Twin City area grow and prosper. At the same time, Drake Bank also provides the best in personal banking products and services to our business clients, their employees, and our neighbors.

CCF focuses on accelerating access to affordable and effective gene therapy treatments for children with ultra-rare genetic diseases. A non-profit model, such as the Columbus Children's Foundation, bridges the innovation gap to change the treatment landscape to ensure no child with these ultra-rare diseases is left behind. The Foundation identifies promising research focused on genetic diseases, chiefly muscular or neurodegenerative disorders affecting children, and offers access to its network of scientific experts, breakthrough technology and manufacturing resources. This accelerates the development and advancement of treatments for patients with these ultra-rare conditions while also lowering costs for life-changing therapies. The Foundation supports efforts to accelerate therapeutic development, increase treatment affordability, and ensure access for children and their families no matter where they live in the world.

RoverMed BioSciences developed a precision targeted nano-capsule capable of delivering drugs directly into the nucleus of diseases cells -- regardless of where they are located in the body. With our crystallized ultra-small particle (CUSP) we have the potential to enable an entire class of biologic drugs for patients with challenging diseases.

GeneSegues Therapeutics is a biopharmaceutical company specializing in the innovation of DNA and RNAi cancer therapeutics. It is the most promising RNAi cancer drug technology/effective delivery system in the world with which to attack metastatic disease spread from the primary tumor which is the core of what leads to 90% of all cancer deaths. The GeneSegues Therapeutics technology is a precision-targeted method for addressing tumors and can finally put a real dent in Cancer!

https://regents.umn.eduThe role of the Board of Regents is clarify the mission of the University of Minnesota (University) and approve programs necessary to fulfill that mission. Monitor and evaluate the performance of the institution in achieving its goals and fulfilling its mission. Appoint, monitor, advise, motivate, support, evaluate, and, if necessary or advisable, replace the president. Approve major policies, long-range plans, educational programs, and annual budgets, while clearly delegating administrative responsibilities.Accept fiduciary responsibility for the long-term welfare of the University.

We provide strategic advice, foundation governance strategy, corporate board analysis and evaluation, investor relations, and organizational development consulting services for clients.